Access to POEMs and Essential Evidence Plus will no longer be included in CMA membership as of Dec. 1, 2023.
Clinical Question
Is doxepin mouthwash or diphenhydramine-lidocaine-antacid mouthwash more effective than placebo for reducing radiation-induced oral mucositis pain?
Bottom line
Both doxepin mouthwash and diphenhydramine-lidocaine-antacid mouthwash significantly reduced pain more than placebo in adults with radiation-induced oral mucositis pain. However, the differences did not meet the predetermined minimal clinically important reduction in pain scores, and there were no significant group differences in additional analgesic use or patient preference for continued therapy. 1b
Reference
Study design: Randomized controlled trial (double-blinded)
Funding: Foundation
Setting: Outpatient (any)
Synopsis
These investigators identified 275 patients, 18 years or older, undergoing radiotherapy for head and neck cancer. The patients had oral mucositis pain rated at least 4 on a scale of 0 to 10 (where 0 = no pain and 10 = the worst imaginable pain). Patients randomly received (concealed allocation assignment) either (1) doxepin mouthwash; (2) a composition mouthwash of diphenhydramine, lidocaine, and antacid; or (3) placebo mouthwash, administered every 4 hours for up to 7 days. Patients were masked to treatment group assignment, and self-assessed pain using a combination score based on 2 pain questionnaires. The minimal clinically important predetermined difference was a 3.5-point change in pain score. Complete follow-up occurred for all patients at 28 days, with 83% of patients completing the treatment per protocol. Using per-protocol analysis, total pain during the first 4 hours after mouthwash treatment decreased by a between-group difference of 2.9 points for doxepin vs placebo and 3.0 for diphenhydramine-lidocaine-antacid vs placebo. No significant group differences occurred in additional analgesic use or in patient preference for continued therapy. The patients who used doxepin mouthwash reported higher rates of drowsiness, unpleasant taste, and stinging/burning.
Reviewer
David C. Slawson, MD
Professor and Vice Chair of Family Medicine for Education and Scholarship
Atrium Health
Professor of Family Medicine, UNC Chapel Hill
Charlotte, NC